Abbonarsi

A double-blind, block-randomized, placebo-controlled trial to identify the chemical assistance effect of mesna submucosal injection for gastric endoscopic submucosal dissection - 09/04/14

Doi : 10.1016/j.gie.2013.09.027 
Kazuki Sumiyama, MD, PhD 1, , Hirobumi Toyoizumi, MD, PhD 1, Tomohiko R. Ohya, MD, PhD 1, Akira Dobashi, MD 1, Shoryoku Hino, MD, PhD 2, Masakuni Kobayashi, MD 1, 3, Kenichi Goda, MD, PhD 1, Hiroo Imazu, MD, PhD 1, Yumi Kawakita 1, Tomohiko Kato, MD, PhD 1, Hisao Tajiri, MD, PhD 1, 3
1 Department of Endoscopy, The Jikei University School of Medicine, Tokyo, Japan 
2 Department of Neuropsychiatry, Ishikawa Prefectural Takamatsu Hospital, Ishikawa, Japan 
3 Department of Internal Medicine, Division of Gastroenterology and Hepatology, The Jikei University School of Medicine, Tokyo, Japan 

Reprint requests: Kazuki Sumiyama MD, PhD, Department of Endoscopy, The Jikei University School of Medicine 3-25-8 Nishi Shinbashi, Minato-ku, Tokyo 105-8461, Japan.

Abstract

Background

Previous animal studies and a pilot clinical trial demonstrated that submucosal injection of a thiol compound called mesna could chemically soften connective tissues and thus facilitate endoscopic submucosal dissection (ESD).

Objective

To evaluate whether mesna injection could reduce procedural times for gastric ESD.

Design

Double-blind, block-randomized, controlled trial.

Setting

University hospital.

Patients

A total of 101 patients with superficial gastric cancer indicated for ESD were enrolled and randomly assigned to either the mesna or control (saline solution) group.

Intervention

Traditional ESD was performed with a single bolus injection of mesna or saline solution.

Main Outcome Measurements

Time for submucosal dissection (TSD).

Results

En bloc resection was achieved for all lesions in the mesna group (53/53) and 51 of 52 lesions (98.08%) in the control group. TSD was not statistically different between the groups (18.62 ± 13.9 [mean ± SD] minutes for the mesna group and 24.58 ± 24.55 [mean ± SD] minutes for the control group; P = .128), and there were fewer time-consuming cases (times over 30 minutes) in the mesna group compared with controls (7/53 vs 15/52; P = .049). Multivariate regression analysis demonstrated that use of mesna, specimen size, and the presence of fibrous scars were significantly correlated with TSD (P < .05).

Limitations

Single-center study.

Conclusion

TSD was not significantly different between the mesna and control injection groups, but multivariate analysis indicated that mesna injection reduced procedural challenges associated with the submucosal dissection. (Clinical trial registration number: UMIN000003786.)

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : CA-ESD, ESD, TSD


Mappa


 DISCLOSURE: This study was funded by the Department of Endoscopy within the Jikei University School of Medicine. All other authors disclosed no financial relationships relevant to this publication.


© 2014  American Society for Gastrointestinal Endoscopy. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 79 - N° 5

P. 756-764 - maggio 2014 Ritorno al numero
Articolo precedente Articolo precedente
  • Suck-ligate-unroof-biopsy by using a detachable 20-mm loop for the diagnosis and therapy of small subepithelial tumors (with video)
  • Kenneth F. Binmoeller, Janak N. Shah, Yasser M. Bhat, Steve D. Kane
| Articolo seguente Articolo seguente
  • Can patient and pain characteristics predict manometric sphincter of Oddi dysfunction in patients with clinically suspected sphincter of Oddi dysfunction?
  • Joseph Romagnuolo, Peter B. Cotton, Valerie Durkalski, Qi Pauls, Olga Brawman-Mintzer, Douglas A. Drossman, Patrick Mauldin, Kyle Orrell, April W. Williams, Evan L. Fogel, Paul R. Tarnasky, Giuseppe Aliperti, Martin L. Freeman, Richard A. Kozarek, Priya A. Jamidar, C. Mel Wilcox, Jose Serrano, Grace H. Elta

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.